We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.56T
1-Year Est. Return 27.86%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
+4.08%
1 Year Est. Return
+27.86%
3 Year Est. Return
+90.49%
5 Year Est. Return
+115.47%
10 Year Est. Return
+472.96%
AUM
$1.22T
AUM Growth
+$35.8B
Cap. Flow
+$1.4B
Cap. Flow %
0.11%
Top 10 Hldgs %
24.28%
Holding
7,917
New
549
Increased
2,512
Reduced
3,286
Closed
579

Sector Composition

Rank Sector Weight
1 Technology 24.03%
2 Healthcare 9.24%
3 Consumer Discretionary 8.79%
4 Financials 8.61%
5 Industrials 6.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LGL.WS
7026
DELISTED
LGL Group Inc Warrants
LGL.WS
0
MATH icon
7027
Metalpha Technology Holding
MATH
$42.3M
$1 ﹤0.01%
1
ORBS
7028
Eightco Holdings
ORBS
$278M
0
ROMA icon
7029
Roma Green Finance Ltd
ROMA
$520M
$1 ﹤0.01%
2
SILO icon
7030
Silo Pharma
SILO
$3.98M
0
SOBR icon
7031
SOBR Safe
SOBR
$1.63M
0
TANH icon
7032
Tantech Holdings
TANH
$5.89M
0
TAOP icon
7033
Taoping
TAOP
$8.38M
0
TNON icon
7034
Tenon Medical
TNON
$2.71M
0
VNRX icon
7035
VolitionRx Ltd
VNRX
$7.83M
0
PBM icon
7036
Psyence Biomedical
PBM
$13M
0
CERO
7037
DELISTED
CERo Therapeutics
CERO
0
XTIA icon
7038
XTI Aerospace
XTIA
$61.6M
0
SAIH
7039
SAIHEAT Ltd
SAIH
$40.9M
0
NEUP
7040
Neuphoria Therapeutics
NEUP
$20.6M
0
VSA
7041
VisionSys AI
VSA
$10.9M
0
BIMI
7042
DELISTED
BIMI International Medical Inc. Common Stock
BIMI
$1 ﹤0.01%
1
AAAU icon
7043
Goldman Sachs Physical Gold ETF Shares
AAAU
$2.68B
-13,243
Closed -$291K
ABAT icon
7044
American Battery Technology Co
ABAT
$346M
-17,173
Closed -$30.1K
ABX
7045
Abacus Global Management
ABX
$868M
-4,964
Closed -$60.5K
AEI icon
7046
Alset
AEI
$44M
-2
Closed -$1
AER icon
7047
CALL
AerCap
AER
$23.7B
-52,600
Closed -$4.57M
AFRM icon
7048
CALL
Affirm
AFRM
$24.7B
-700
Closed -$26.1K
RYM
7049
RYTHM Inc
RYM
$44.8M
0
AGNG icon
7050
Global X Aging Population ETF
AGNG
$89.3M
-2,972
Closed -$89.5K

Similar funds

JP Morgan Chase's Q2 2024 Portfolio in Review

As of Q2 2024, JP Morgan Chase held 7,917 positions worth $1.22T, up 3% from $1.18T the previous quarter. Its ten largest holdings account for 24% of the portfolio.

JP Morgan Chase's Q2 2024 filing shows 549 new, 2,512 increased, 3,286 reduced and 579 closed positions. Its largest new stake was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M. The largest sale was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $2.4B.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • JP Morgan Chase's largest Q2 2024 buy was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M.
  • JP Morgan Chase added most to Apple in Q2 2024, an estimated $4.65B increase.
  • JP Morgan Chase's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.11B.
  • JP Morgan Chase fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2024, selling an estimated $2.4B.
  • JP Morgan Chase's ten largest holdings make up 24% of its $1.22T portfolio in Q2 2024.
  • JP Morgan Chase opened 549 new positions and closed 579 in Q2 2024.
  • JP Morgan Chase's portfolio value rose 3% quarter-over-quarter to $1.22T.

Based on JP Morgan Chase's 13F filing for Q2 2024, filed 12 Aug 2024.